Jean-Jacques Bienaimé Chief Executive Officer, BioMarin Mr. Bienaimé joined BioMarin in May 2005 as chief executive officer Gilead Sciences, and Blueprint Medicines. Sam_Kintz photo. Sam Kintz, MBA. Co-founder, Chief Executive Officer, and Member of the Board of Directors. Joe
TiEcon 2023 Grand Keynote: Joydeep Ganguly, Gilead, & Mohan Giridharadas, LeanTaaS AMGEN Ventures and Business Development in Los Angeles Gilead Sciences Chairman of the Board & CEO John Martin, Ph.D., discusses HIV treatment innovation and the the potential
How Women Can Become Board Members | Deborah H. Telman, EVP, Corp. Affairs, Gilead Sciences, Inc. Kelsey Louie presents Impact Award to Patrick McGovern How much bioscience business development is really happening in Los Angeles? MODERATOR: Rajit Malhotra, Executive
CNBC's Meg Tirrell reports the latest on Gilead's quarterly earnings amid the CEO's announcement he's stepping down. TiEcon 2023 at Santa Clara Convention Center, May 3-5 Day 2 Grand Keynote: Joydeep Ganguly, Senior Vice President, About This Episode Brad D. Smith, Executive Chairman of the Board of Intuit shares his lessons in leadership and the role of a
Daniel O'Day of Gilead Sciences Becomes New Chair of PhRMA Full Show - "Connect17" Series
Committee Composition · Lead Independent Director · Board Chair · Committee Member · Committee Chair. Promising Coronavirus Treatment On The Way?
James Sapirstein has served over thirty-five years in the pharmaceutical industry. He is currently the President and CEO of AzurRx The company's Board of Directors has declared an increase of 2.6% in the company's quarterly cash dividend, beginning in the first quarter of 2025.
Hear from Steve Sitto Welcome to THE JUNGLE – the wild and exciting world of business. The second episode in the COVID-19 series features a
The Hamilton Review Ep. 208: John Cogan on the National Debt Crisis Plaguing our Country Where Courage Stems From as a Minority | Deb Telman, EVP, Corp. Affairs, Gilead Sciences, Inc. The Challenges of Drug Development During COVID-19
Ample research shows that companies with diverse boards are more innovative and higher performing. Get an inside look at one Deborah Gordon from the HBA Global Board of Directors interviews Devi SenGupta, Gilead. #HBAWOTY24 #HBAimpact.
Gilead Sciences, Inc. As part of her appointment to the Board of members of our board of directors, specifically Ms. Tomasello, and #BreakingNow | Briefing by pharma CEOs on #COVID19 drugs, organised by #IFPMA | 03-09-20 Welcome to this special mash-up episode, where Shellye Archambeau, Former CEO, MetricStream, Advisor & Author, Deborah H.
Global Virus Network (GVN) Adds Gilead Sciences to GVN Box CEO Aaron Levie on Starboard proxy fight: Happy overall with relationship Box CEO Aaron Levie joins 'Tech Check' to discuss the Starboard Ventures proxy fight and how it has changed the company.
Board and staff of Positive Women's Network USA reflect on our origins, growth, and future after 10 years of power. N. Anthony Coles, MD Chairman & CEO, Onyx Pharmaceuticals Dr. Coles joined Onyx in March 2008 as President and Chief
Gilead Sciences Board of Directors Welcome to the Connect17 Conference, Disruptive Technologies that Impact our Communities. Speakers: Kacy Hutchison Vice
Gilead Science | Covid -19 Treatment | CEO Daniel O' Day Speech | Pharma Industry Deepening the U.S.-India Commercial Partnership: Make in India Campaign FBN's Charlie Gasparino with the latest on the CBS investigation into sexual misconduct allegations against CEO Leslie Moonves.
Black Women Leaders: A Competitive Advantage Leadership | Board of Directors | Scientific Advisors | Enliven Board of Directors. Albert Bourla of Pfizer and Paul Hudson of Sanofi also assumed new leadership positions on the PhRMA board. "PhRMA and
Mingle Media TV and Red Carpet Report host, Linda Antwi, were invited to cover the 44th NAACP Image Awards Pre-Gala Monkeypox: The Response and What's Next The Southern AIDS Coalition (SAC) initially launched SPARK! (Southerners Promoting Awareness, Resources & Knowledge) in
The Mechanics of Pharma M&A with Gilead's Devang Bhuta: Bhuta, Gilead's SVP of corporate development, sits down with At "Connect," we explore of how technologies continue to shape our society by focusing on social impact and beneficial use.
John Bryant – Former Chairman and CEO of Kellogg's | THE JUNGLE #2 Session 2: CEO Perspectives othe Economy John C. Martin, PhD, Chairman and CEO, Gilead Sciences and Meg Whitman, Daniel P. O'Day, Chairman and Chief Executive Officer, Gilead Sciences, Inc. Jacqueline K. Barton, PhD, Jacqueline K. Barton, PhD, Professor Emerita,
In May 2022, an outbreak of monkeypox, a viral disease, was confirmed. It quickly spread from the United Kingdom to many The College of Computer and Mathematical and Natural Sciences in collaboration with the University of Maryland Alumni
Painting the Art of the Possible with Brad D. Smith Gilead beats, announces CEO stepping down Our Board of Directors oversees the management and risks of our business and is responsible for upholding all our corporate values of integrity, inclusion,
On June 2, we hosted an impactful roundtable discussion with Bay Area leaders to tackle the future of work in an evolving world. Cabaletta Bio Appoints Global Commercial Leader Shawn
SAC Spotlight on PPN v6 This coronavirus drug seems promising. Ana Kasparian and John Iadarola discuss on The Young Turks. Keep Hope (and TYT) In this heartfelt episode of The Patient From Hell, host Samira Daswani talks to Jill Massey, a pharmacist and pharma industry
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company's Board of Directors. How Women Can Become Board Members | Deb Telman, EVP, Corporate Affairs, Gilead Sciences, Inc. John C Martin and Meg Whitman -- SIEPR Economic Summit 2012
Board of Directors | Gilead Anthony Welters Joins Gilead Sciences' Board of Directors
Seeding and Supporting Early-Stage Biotech Companies with Xontogeny CEO Chris Garabedian Digital Press Briefing: First Lenacapavir Delivery in Africa
James Sapirstein, President and CEO at AzurRx BioPharma Kelsey Louie, CEO of GMHC, presents the 2016 Harlem United Impact Award to Patrick McGovern, Senior Director of Government We are happy to welcome John Cogan, a Senior Fellow at the Hoover Institution, to The Hamilton Review Podcast!
Patient from Hell Ep 79: Navigating Life's Curveballs: From Caregiver to Cancer Survivor PDA West Coast Chapter: 2024 Wrapped uesday, November 18, 2025. Digital Press Briefing on breakthrough HIV drug Lenacapavir's Delivery and the America First Global
Donna Meyer #AsksTheCEO of Gilead to Factor in Public Investment into Covid-19 Vaccine Pricing Connect17 - Pt. 2 of 2
Newsupdate Live #LiveStream #NewsNow | GENEVA - Briefing with ceos of major pharmaceuticals on drugs in the pipeline Janice is joined by Robin Washington, Board director of Alphabet, Inc., Honeywell International Inc., Mastercard Foundation,
2:30 pm Panel: Make in India Campaign Hon. B.J. Panda Member of Parliament, Biju Janata Dal (BJD) Party Joseph Alhadeff Corporate Leadership Roundtable - June 2, 2021
PWN: 10 Years Fierce In this episode, Julie Gerberding, M.D., Chief Executive Officer for the Foundation for the National Institutes of Health speaks with Health Equity & Innovation: A Case Study on Importance of Board Diversity
2021 WBC Summit Breakout Session: Women's Leadership in Healthcare The U.S. government has given Gilead Sciences substantial funding to develop Covid-19 related products. Here, Donna Meyer CBS Board weighs future of Leslie Moonves
Gilead Sciences, Inc. - Gilead Sciences Announces 2.6 Percent Connect17 - Pt. 1 of 2 John Martin
Board of Directors · Daniel O'Day · Jacqueline K. Barton, PhD · Jeffrey A. Bluestone, PhD · Sandra J. Horning, MD · Kelly A. Kramer · Ted W. Love, MD · Harish Manwani. Board of Directors and Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the
Grand Keynote I Daniel O'Day, Gilead Sciences Inc and Rich Karlgaard I TiEcon 2021 The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences John C. Martin, Ph.D. Chairman of the Board and Chief Executive Officer.
Gilead CEO John Martin, PhD Merline Saintil & Robin Washington from Black Women on Boards joins NYSE TV Women comprise 80% of the healthcare workforce but only about 20% of the leadership positions across healthcare industries.
Part 1 - "Connect17" Series N. Anthony Coles, MD, Chairman & CEO, Onyx Pharmaceuticals, Inc. Grand Keynote at TiEcon 2021 with Gilead Chairman and CEO, Daniel O'Day and Rich Karlgaard conversation about Innovating
The women behind accelerating Black female leaders into board seats, Black Women on Boards, visits the NYSE to talk more Keys to the Boardroom, Hosted by Gilead #BEWPS
Video Breif : Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that Committee Composition - Gilead Sciences, Inc. - Governance
Diversity in the C-Suite | Shellye Archambeau, Deb Telman, & Fawn Lopez 2024 HBA Woman of the Year Red Carpet Interview with Devi SenGupta Gillead CEO John Martin on the value CHI delivers for his company and the entire California biomedical community.
Gilead Sciences, Inc. - Governance - Board of Directors Rosalyn M. Brock, Chairman of the Board, NAACP at 44th NAACP Image Awards Pre-Show Gala In this episode, Mark talks with Chris Garabedian, Chairman and CEO of Xontogeny, which he founded in 2016 to support multiple
Gilead Sciences CEO John Martin, Ph.D., on HIV Treatment Innovation & Healthcare Reform Wrapped is here. Check out some of our chapter's favorite moments from 2024! PDA WCC Board Officers: Stephanie Lee, Yashu
Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin Pharmaceutical Inc. Hear from Steve Sitto Associate Director, Global Travel, Meetings, & Events, Gilead Sciences running for GBTA President - Board
If you're ready to make an impact on a larger scale, come hear what it takes to serve on a corporate board and how to best